Thursday, February 15, 2024

Global Protein Expression Service Market Research Report 2024

What is Global Protein Expression Service Market?

The Global Protein Expression Service Market is a vast and dynamic field that focuses on the production of specific proteins through biotechnology. This market is crucial in the world of scientific research and commercial production, as proteins are the building blocks of life and play a vital role in the functioning of all living organisms. The global Protein Expression Service market was valued at a whopping US$ 12400 million in 2023 and is expected to soar to US$ 19520 million by 2030. This impressive growth, with a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period of 2024 to 2030, is a testament to the increasing demand and importance of protein expression services in various sectors.

Protein Expression Service Market

Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Yeast Cell Expression Systems, Others in the Global Protein Expression Service Market:

The Global Protein Expression Service Market is segmented into Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Yeast Cell Expression Systems, and others. Prokaryotic Expression Systems, primarily bacteria, are the most commonly used systems due to their fast growth, high yield, and low cost. Mammalian Cell Expression Systems are used when complex proteins requiring specific post-translational modifications are needed. Yeast Cell Expression Systems are a middle ground, offering some of the advantages of both prokaryotic and mammalian systems. Other systems include insect cells and plant cells, each with their unique advantages and applications.

Commercial, Academic Research in the Global Protein Expression Service Market:

The Global Protein Expression Service Market finds its usage in two major areas: Commercial and Academic Research. In the commercial sector, protein expression services are used in the production of industrial enzymes, therapeutic proteins, and vaccines. They are also used in the development of biosimilars, which are biological products highly similar to an already approved biological product. In the realm of academic research, protein expression services are indispensable in studying protein function, structure, and interactions. They are also used in the development of new therapeutic strategies and in the understanding of various diseases at the molecular level.

Global Protein Expression Service Market Outlook:

To put it in simpler terms, protein production, which is the process of generating a specific quantity of a particular protein, is a crucial aspect of biotechnology. The global Protein Expression Service market, which was valued at US$ 12400 million in 2023, is projected to reach a staggering US$ 19520 million by 2030. This indicates a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period from 2024 to 2030. This growth is a clear indication of the increasing demand and significance of protein expression services across various sectors.


Report Metric Details
Report Name Protein Expression Service Market
Accounted market size in 2023 US$ 12400 million
Forecasted market size in 2030 US$ 19520 million
CAGR 7.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Prokaryotic Expression Systems
  • Mammalian Cell Expression Systems
  • Yeast Cell Expression Systems
  • Others
Segment by Application
  • Commercial
  • Academic Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Synthesis, Sigma-Aldrich, Thermo Fisher Scientific, NEB, GenScript, ATUM, Promega, Lucigen, Bitesize Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Protein Production Service Market Research Report 2024

What is Global Protein Production Service Market?

The Global Protein Production Service Market is a vast and dynamic sector that focuses on the production of proteins through various biotechnological methods. This market is crucial as proteins are the building blocks of life, playing a key role in every biological process. They are essential for the structure, function, and regulation of the body's tissues and organs. The global Protein Production Service market was valued at US$ 12400 million in 2023 and is expected to reach US$ 19520 million by 2030, growing at a CAGR of 7.0% during the forecast period 2024-2030. This growth is driven by the increasing demand for protein-based therapeutics and diagnostics, advancements in protein production technologies, and the rising prevalence of chronic diseases. The market is also influenced by the increasing investment in research and development activities by key market players.

Protein Production Service Market

Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Yeast Cell Expression Systems, Others in the Global Protein Production Service Market:

The Global Protein Production Service Market is segmented based on different expression systems such as Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Yeast Cell Expression Systems, and others. Each of these systems has its unique advantages and applications. Prokaryotic Expression Systems, for instance, are widely used due to their cost-effectiveness and high yield of protein production. Mammalian Cell Expression Systems, on the other hand, are preferred for the production of complex proteins as they can perform post-translational modifications. Yeast Cell Expression Systems are known for their rapid growth and scalability. Other expression systems include insect cell, plant cell, and algal cell expression systems. These systems are chosen based on the type of protein to be produced, the required yield, and the cost of production.

Commercial, Academic Research in the Global Protein Production Service Market:

The Global Protein Production Service Market finds its usage in various areas such as Commercial and Academic Research. In the commercial sector, protein production services are used in the development of new drugs, vaccines, and therapeutic proteins. These services are also used in the production of industrial enzymes and biofuels. In academic research, protein production services are used in the study of protein structure and function, protein-protein interactions, and in the development of new protein production technologies. The demand for protein production services in both these sectors is expected to increase in the coming years due to the growing need for new and effective therapeutics and the increasing investment in research and development activities.

Global Protein Production Service Market Outlook:

The outlook for the Global Protein Production Service Market is promising. Protein production, a method of generating a specific quantity of a particular protein, is a critical process in biotechnology. The market, which was valued at US$ 12400 million in 2023, is projected to reach US$ 19520 million by 2030. This represents a compound annual growth rate (CAGR) of 7.0% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing demand for protein-based therapeutics and diagnostics, advancements in protein production technologies, and the rising prevalence of chronic diseases. The market is also influenced by the increasing investment in research and development activities by key market players.


Report Metric Details
Report Name Protein Production Service Market
Accounted market size in 2023 US$ 12400 million
Forecasted market size in 2030 US$ 19520 million
CAGR 7.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Prokaryotic Expression Systems
  • Mammalian Cell Expression Systems
  • Yeast Cell Expression Systems
  • Others
Segment by Application
  • Commercial
  • Academic Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Synthesis, Sigma-Aldrich, Thermo Fisher Scientific, NEB, GenScript, ATUM, Promega, Lucigen, Bitesize Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Custom Gene Expression Market Research Report 2024

What is Global Custom Gene Expression Market?

The Global Custom Gene Expression Market is a rapidly expanding field that focuses on the creation of custom genes for use in various applications. This market involves the design and synthesis of genes, which are then expressed in a host organism to produce a desired protein. The process involves the use of advanced genetic engineering techniques to modify the DNA sequence of a gene, allowing for the creation of genes with specific characteristics. This market is driven by the increasing demand for personalized medicine, advancements in genetic engineering, and the growing need for efficient drug discovery and development processes. The custom gene expression market is also being propelled forward by the increasing prevalence of genetic disorders and the need for effective treatments. The market is further segmented based on the length of the gene, with segments for genes below 1000 base pairs (bp), between 1001 and 3000 bp, between 3001 and 5000 bp, and above 5000 bp.

Custom Gene Expression Market

Below 1000 bp, 1001 - 3000 bp, 3001- 5000 bp, Above 5000 bp in the Global Custom Gene Expression Market:

The Global Custom Gene Expression Market is segmented based on the length of the gene, with categories for genes below 1000 base pairs (bp), between 1001 and 3000 bp, between 3001 and 5000 bp, and above 5000 bp. Each segment has its own unique applications and uses. Genes below 1000 bp are often used in basic research and in the development of genetic therapies. Genes between 1001 and 3000 bp are commonly used in the production of proteins for use in drug discovery and development. Genes between 3001 and 5000 bp are typically used in the creation of complex proteins and in the study of gene function. Genes above 5000 bp are often used in the production of large proteins and in the development of gene therapies. Each segment of the market has its own unique challenges and opportunities, and the growth of each segment is driven by the increasing demand for custom genes in various applications.

Academic Research, Commercial in the Global Custom Gene Expression Market:

The Global Custom Gene Expression Market has a wide range of applications, with the market being divided into two main segments: academic research and commercial use. In academic research, custom gene expression is used in the study of gene function, the development of new therapies, and the advancement of our understanding of genetics. This often involves the creation of custom genes for use in laboratory experiments, with the results of these experiments contributing to the advancement of the field of genetics. In the commercial sector, custom gene expression is used in the development of new drugs, the production of proteins for use in various industries, and the creation of genetically modified organisms. The growth of the market in both these sectors is driven by the increasing demand for custom genes and the advancements in genetic engineering techniques.

Global Custom Gene Expression Market Outlook:

Looking at the market outlook for the Global Custom Gene Expression Market, it's clear that this is a field with significant growth potential. In 2023, the market was valued at US$ 512 million. However, it's projected to reach a staggering US$ 1570.7 million by 2030. This represents a compound annual growth rate (CAGR) of 17.3% during the forecast period from 2024 to 2030. This impressive growth is driven by a number of factors, including the increasing demand for personalized medicine, advancements in genetic engineering, and the growing need for efficient drug discovery and development processes. The market is also being propelled forward by the increasing prevalence of genetic disorders and the need for effective treatments.


Report Metric Details
Report Name Custom Gene Expression Market
Accounted market size in 2023 US$ 512 million
Forecasted market size in 2030 US$ 1570.7 million
CAGR 17.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Below 1000 bp
  • 1001 - 3000 bp
  • 3001- 5000 bp
  • Above 5000 bp
Segment by Application
  • Academic Research
  • Commercial
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Bio Basic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Oligonucleotide Synthesis Services Market Research Report 2024

What is Global Oligonucleotide Synthesis Services Market?

The Global Oligonucleotide Synthesis Services Market is a rapidly growing sector in the biotechnology industry. Oligonucleotides are short DNA or RNA molecules that are used in genetic testing, research, and forensics. The synthesis of these molecules is a complex process that requires specialized equipment and expertise. The market for these services is expanding as the demand for personalized medicine and genetic research increases. Companies in this market provide services such as custom oligonucleotide synthesis, design and optimization, and large-scale production. The market is driven by the increasing use of synthesized oligonucleotides in clinical applications, advancements in oligonucleotide synthesis technologies, and the growing focus on personalized medicine.

Oligonucleotide Synthesis Services Market

Intermediate-scale Synthesis Oligos, Large-scale Synthesis Oligos in the Global Oligonucleotide Synthesis Services Market:

The Global Oligonucleotide Synthesis Services Market is segmented into Intermediate-scale Synthesis Oligos and Large-scale Synthesis Oligos. Intermediate-scale synthesis oligos are used in applications such as PCR, sequencing, and gene synthesis. They are typically synthesized in quantities of 1-100 micromoles. On the other hand, large-scale synthesis oligos are used in applications that require large quantities of oligonucleotides, such as drug discovery and therapeutic applications. These are typically synthesized in quantities of 100 micromoles to several grams. The choice between intermediate and large-scale synthesis depends on the specific needs of the project, including the quantity of oligonucleotides required and the complexity of the sequence.

Commercial, Academic Research in the Global Oligonucleotide Synthesis Services Market:

The Global Oligonucleotide Synthesis Services Market finds its usage in various areas including Commercial and Academic Research. In the commercial sector, these services are used in the development of new drugs and therapies, particularly in the field of personalized medicine. They are also used in diagnostic applications, such as genetic testing and disease detection. In academic research, synthesized oligonucleotides are used in a wide range of applications, from basic genetic research to the development of new therapeutic strategies. The demand for these services in both sectors is driven by the increasing importance of genetic research and the growing need for personalized therapies.

Global Oligonucleotide Synthesis Services Market Outlook:

The Global Oligonucleotide Synthesis Services Market has shown significant growth in recent years. In 2023, the market was valued at US$ 814 million. It is projected to reach a value of US$ 1272.2 million by 2030, representing a compound annual growth rate (CAGR) of 6.6% during the forecast period from 2024 to 2030. This growth is driven by several factors, including advancements in oligonucleotide synthesis technologies, the increasing use of synthesized oligonucleotides in clinical applications, and the growing focus on personalized medicine.


Report Metric Details
Report Name Oligonucleotide Synthesis Services Market
Accounted market size in 2023 US$ 814 million
Forecasted market size in 2030 US$ 1272.2 million
CAGR 6.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Intermediate-scale Synthesis Oligos
  • Large-scale Synthesis Oligos
Segment by Application
  • Commercial
  • Academic Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Bio Basic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global DNA Oligonucleotide Synthesis Market Research Report 2024

What is Global DNA Oligonucleotide Synthesis Market?

The Global DNA Oligonucleotide Synthesis Market is a rapidly growing sector in the biotechnology industry. It involves the production of short, single-stranded DNA molecules, known as oligonucleotides, which are crucial in genetic testing, research, and forensics. These oligonucleotides are synthesized chemically and are used in various applications such as diagnostics, therapeutics, and in the development of new drugs. The market for DNA Oligonucleotide Synthesis is driven by the increasing demand for innovative diagnostic and therapeutic techniques, advancements in synthetic biology, and the growing field of personalized medicine. The market is also influenced by the rising prevalence of genetic disorders and infectious diseases, which require DNA oligonucleotides for diagnosis and treatment.

DNA Oligonucleotide Synthesis Market

Intermediate-scale Synthesis Oligos, Large-scale Synthesis Oligos in the Global DNA Oligonucleotide Synthesis Market:

The Global DNA Oligonucleotide Synthesis Market is segmented into Intermediate-scale Synthesis Oligos and Large-scale Synthesis Oligos. Intermediate-scale Synthesis Oligos are used in applications that require a moderate amount of oligonucleotides, such as in the development of diagnostic assays and therapeutic applications. On the other hand, Large-scale Synthesis Oligos are used in applications that require a large quantity of oligonucleotides, such as in high-throughput screening and in the production of DNA vaccines and gene therapies. The demand for both types of synthesis oligos is increasing due to the growing need for high-quality, reliable, and cost-effective oligonucleotides in various applications.

Commercial, Academic Research in the Global DNA Oligonucleotide Synthesis Market:

The Global DNA Oligonucleotide Synthesis Market finds its usage in various areas such as Commercial and Academic Research. In the commercial sector, DNA oligonucleotides are used in the development of new drugs, diagnostic assays, and therapeutic applications. They are also used in the production of DNA vaccines and gene therapies. In academic research, DNA oligonucleotides are used in various research studies related to genetics, molecular biology, and biochemistry. They are also used in the study of DNA-protein interactions, DNA structure, and function, and in the development of new techniques for DNA manipulation and analysis.

Global DNA Oligonucleotide Synthesis Market Outlook:

The future of the Global DNA Oligonucleotide Synthesis Market looks promising. In 2023, the market was valued at US$ 814 million. It is expected to grow significantly and reach a value of US$ 1272.2 million by 2030. This represents a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period from 2024 to 2030. This growth is driven by the increasing demand for DNA oligonucleotides in various applications, advancements in synthetic biology, and the growing field of personalized medicine.


Report Metric Details
Report Name DNA Oligonucleotide Synthesis Market
Accounted market size in 2023 US$ 814 million
Forecasted market size in 2030 US$ 1272.2 million
CAGR 6.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Intermediate-scale Synthesis Oligos
  • Large-scale Synthesis Oligos
Segment by Application
  • Commercial
  • Academic Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Genescript, GeneArt (Thermofischer), Renesas Electronics Corporation, DNA 2.0 (ATUM), OriGene, BBI, Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Bio Basic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Alunbrig Market Research Report 2024

What is Global Alunbrig Market?

The Global Alunbrig Market is a specialized segment of the pharmaceutical industry that focuses on the production and distribution of Alunbrig, a medication used in the treatment of non-small cell lung cancer. This market has a global reach, with key players operating in various regions around the world. The Alunbrig market is characterized by rigorous research and development activities, stringent regulatory frameworks, and a high degree of competition among market participants. The market dynamics are influenced by a variety of factors, including advancements in medical technology, changes in healthcare policies, and the prevalence of lung cancer. The Global Alunbrig Market is a critical component of the broader pharmaceutical industry, contributing to the development of effective treatment options for patients worldwide.

Alunbrig Market

30mg, 50mg, 180mg in the Global Alunbrig Market:

The Global Alunbrig Market offers Alunbrig in three different dosages: 30mg, 50mg, and 180mg. Each dosage is designed to cater to the specific needs of patients, taking into account factors such as the severity of the disease, the patient's overall health condition, and their response to treatment. The 30mg dosage is typically prescribed for patients in the early stages of lung cancer, while the 50mg and 180mg dosages are used for more advanced cases. The availability of different dosages allows healthcare providers to customize treatment plans, thereby enhancing the effectiveness of the medication. The Global Alunbrig Market is committed to ensuring the availability of these dosages to meet the diverse needs of patients worldwide.

Hospital, Pharmacy in the Global Alunbrig Market:

The Global Alunbrig Market serves two primary areas: hospitals and pharmacies. In hospitals, Alunbrig is used as part of the treatment regimen for patients diagnosed with non-small cell lung cancer. It is administered under the supervision of healthcare professionals, ensuring that patients receive the appropriate dosage and that any side effects are promptly managed. On the other hand, pharmacies play a crucial role in the distribution of Alunbrig. They provide patients with convenient access to the medication, allowing them to continue their treatment at home. Both hospitals and pharmacies are essential components of the Global Alunbrig Market, facilitating the delivery of effective lung cancer treatment to patients.

Global Alunbrig Market Outlook:

The Global Alunbrig Market has shown significant growth over the years. In 2023, the market was valued at US$ 182.9 million. However, it is projected to reach a staggering US$ 349.7 million by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period from 2024 to 2030. This growth can be attributed to the increasing prevalence of lung cancer and the ongoing advancements in medical technology. In the broader context, the global pharmaceutical market is expected to grow at a CAGR of 5% over the next six years, reaching 1475 billion USD in 2022. The chemical drug market, a subset of the pharmaceutical industry, is also expected to see growth, with estimates suggesting an increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. These trends indicate a positive outlook for the Global Alunbrig Market, signaling opportunities for further growth and development.


Report Metric Details
Report Name Alunbrig Market
Accounted market size in 2023 US$ 182.9 million
Forecasted market size in 2030 US$ 349.7 million
CAGR 6.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 30mg
  • 50mg
  • 180mg
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-

Global Brigatinib Tablet Market Research Report 2024

What is Global Brigatinib Tablet Market?

The Global Brigatinib Tablet Market is a specialized sector of the pharmaceutical industry that focuses on the production and distribution of Brigatinib tablets, a targeted therapy used in the treatment of non-small cell lung cancer. This market is a subset of the global pharmaceutical market, which encompasses a wide range of medications and therapies. The Brigatinib Tablet Market is a crucial component of the global healthcare system, as it provides a vital treatment option for patients suffering from a specific type of lung cancer. The market operates on a global scale, with key players and consumers spread across various countries and regions. The market dynamics are influenced by a variety of factors, including advancements in medical research, changes in healthcare policies, and fluctuations in demand and supply. The Global Brigatinib Tablet Market is characterized by intense competition, with several pharmaceutical companies vying for a larger market share.

Brigatinib Tablet Market

30mg, 50mg, 180mg in the Global Brigatinib Tablet Market:

The Global Brigatinib Tablet Market offers Brigatinib tablets in various dosages, including 30mg, 50mg, and 180mg. These different dosages cater to the varying needs of patients, based on the severity of their condition and their body's response to the medication. The 30mg tablet is typically used as a starting dose, which may be increased to 50mg or 180mg depending on the patient's tolerance and the progression of the disease. The market for each dosage is influenced by factors such as the prevalence of non-small cell lung cancer, the efficacy of the medication, and the prescribing habits of healthcare professionals. The 180mg tablet, being the highest dosage, is expected to command a significant share of the market due to its increased efficacy in controlling the disease. However, the demand for 30mg and 50mg tablets is also substantial, as these dosages are often used in the initial stages of treatment.

Hospital, Pharmacy in the Global Brigatinib Tablet Market:

The Global Brigatinib Tablet Market serves a wide range of end-users, including hospitals and pharmacies. Hospitals are a major consumer of Brigatinib tablets, as they provide comprehensive care for patients with non-small cell lung cancer, including diagnosis, treatment, and follow-up. The use of Brigatinib tablets in hospitals is facilitated by oncologists, who prescribe the medication based on the patient's condition. On the other hand, pharmacies, both physical and online, play a crucial role in the distribution of Brigatinib tablets. They ensure that the medication is readily available for patients, thereby contributing to the accessibility and affordability of cancer treatment. The role of pharmacies is particularly important in regions where hospital facilities are limited or overcrowded. The usage of Brigatinib tablets in these two sectors is expected to increase in the coming years, driven by the rising incidence of non-small cell lung cancer and the growing awareness about the benefits of targeted therapies.

Global Brigatinib Tablet Market Outlook:

The future outlook for the Global Brigatinib Tablet Market is promising, with the market value expected to nearly double from US$ 182.9 million in 2023 to US$ 349.7 million by 2030. This growth is anticipated to occur at a compound annual growth rate (CAGR) of 6.7% during the forecast period from 2024 to 2030. This projection is in line with the overall growth trend of the global pharmaceutical market, which is expected to reach 1475 billion USD in 2022, growing at a CAGR of 5% over the next six years. The chemical drug market, a key segment of the pharmaceutical industry, is also projected to experience growth, with its value estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. These trends indicate a positive trajectory for the Global Brigatinib Tablet Market, driven by advancements in medical research, increased healthcare spending, and the growing prevalence of non-small cell lung cancer.


Report Metric Details
Report Name Brigatinib Tablet Market
Accounted market size in 2023 US$ 182.9 million
Forecasted market size in 2030 US$ 349.7 million
CAGR 6.7%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • 30mg
  • 50mg
  • 180mg
Segment by Application
  • Hospital
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends
-
Subscribe to: Comments (Atom)

Global TEC Semiconductor Air Conditioner Market Research Report 2025

What is Global TEC Semiconductor Air Conditioner Market? The Global TEC Semiconductor Air Conditioner Market is a specialized segment withi...